Back to News
AI
Biossil raises $153-million in OpenAI-led funding to bring resuscitated drugs to market
Biztoc.com·September 28, 2026·1 min read
AI Summary
OpenAI has led a US$153-million venture capital financing of Biossil Inc. , a Toronto startup that uses artificial intelligence to give failed drug candidates a second chance at becoming approved therapies.
From the source
OpenAI has led a US$153-million venture capital financing of Biossil Inc., a Toronto startup that uses artificial intelligence to give failed drug candidates a second chance at becoming approved therapies. The AI giant, best known for ChatGPT, provided the ma…
The full text couldn't be loaded here (the source may require a subscription).
View original at Biztoc.comKeep reading
Trump announces vague ‘morally binding’ AI deal among tech CEOs for ‘tremendous self-policing’ - The Guardiantheguardian.com · 1h agoWhite House unveils ‘super intelligence’ executive order and industry accord - nextgov.comnextgov.com · 1h agoTrump orders federal government to replace ‘artificial intelligence’ with ‘super intelligence’ - Anadolu Ajansıaa.com.tr · 1h agoTrump signs executive order officially renaming artificial intelligence ‘Super Intelligence’ - Fox Newsfoxnews.com · 2h ago
Was this useful?